Drug Shortage Report for BELKYRA
Report ID | 141860 |
Drug Identification Number | 02443910 |
Brand name | BELKYRA |
Common or Proper name | deoxycholic acid injection |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEOXYCHOLIC ACID |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 4 x 2mL vial |
ATC code | D11AX |
ATC description | OTHER DERMATOLOGICAL PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-07-05 |
Actual start date | |
Estimated end date | 2021-08-31 |
Actual end date | 2021-09-07 |
Shortage status | Resolved |
Updated date | 2021-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-09-22 | English | Compare |
v3 | 2021-07-06 | English | Compare |
v2 | 2021-07-05 | French | Compare |
v1 | 2021-07-05 | English | Compare |
Showing 1 to 4 of 4